FLEXIBLE PREMIUM DEFERRED VARIABLE ANNUITY

[Pages:7]THRIVENT FLEXIBLE PREMIUM DEFERRED VARIABLE ANNUITY

Issued by Thrivent Life Insurance Company, formerly LBVIP, between 2/18/1988 and 4/30/2003. Thrivent replaced Thrivent Life as the issuer on July 1, 2019.

Prospectuses April 30, 2020 Thrivent Variable Annuity Account C Thrivent Series Fund, Inc.

Thrivent Series Fund, Inc.

Supplement to Prospectus and Thrivent Partner Growth Stock Portfolio Summary Prospectus

each dated April 30, 2020

The Board of Directors of Thrivent Series Fund, Inc. has approved the merger of Thrivent Partner Growth Stock Portfolio (the "Target Portfolio") into Thrivent Large Cap Growth Portfolio. The merger is subject to approval by contractholders of the Target Portfolio at a special meeting of contractholders to be held on or about August 24, 2020. The merger, if approved by contractholders, will occur on or about August 31, 2020. The Target Portfolio and its corresponding subaccount will be closed as new investment selections at the end of the day on July 17, 2020. If you already invest in a subaccount corresponding to the Target Portfolio, you can continue to invest in the subaccount until the merger has been completed.

The date of this Supplement is June 24, 2020.

Please include this Supplement with your Prospectus.

36049

THRIVENT VARIABLE LIFE ACCOUNT I THRIVENT VARIABLE INSURANCE ACCOUNT A THRIVENT VARIABLE INSURANCE ACCOUNT B

THRIVENT VARIABLE ANNUITY ACCOUNT I THRIVENT VARIABLE ANNUITY ACCOUNT II THRIVENT VARIABLE ANNUITY ACCOUNT A THRIVENT VARIABLE ANNUITY ACCOUNT B THRIVENT VARIABLE ANNUITY ACCOUNT C

Supplement to the Prospectus dated April 30, 2020 with respect to

Thrivent Partner Growth Stock Portfolio

The Board of Directors of Thrivent Series Fund, Inc. has approved the merger of Thrivent Partner Growth Stock Portfolio (the "Target Portfolio") into Thrivent Large Cap Growth Portfolio. The merger is subject to approval by contractholders of the Target Portfolio at a special meeting of contractholders to be held on or about August 24, 2020. The merger, if approved by contractholders, will occur on or about August 31, 2020. The Target Portfolio and its corresponding subaccount will be closed as new investment selections at the end of the day on July 17, 2020. If you already invest in a subaccount corresponding to the Target Portfolio, you can continue to invest in the subaccount until the merger has been completed.

The date of this Supplement is June 24, 2020.

36049A

Thrivent Series Fund, Inc.

Supplement to Prospectus and Thrivent Partner Healthcare Portfolio Summary Prospectus,

each dated April 30, 2020

1. Xiang Liu, PhD and Jeff Lee joined Erin Xie, PhD as portfolio co-managers of Thrivent Partner Healthcare Portfolio in June 2020. The following replaces similar information for Thrivent Partner Healthcare Portfolio found in the "Summary Section" under the heading "Portfolio Manager(s)" and in the "Management of the Portfolios" section under the heading "Portfolio Management":

Erin Xie, PhD, Xiang Liu, PhD, and Jeff Lee are jointly and primarily responsible for the day-to-day management of the Portfolio. Dr. Xie, Managing Director of BlackRock, Inc. ("BlackRock"), has served as a portfolio manager of the Portfolio since September 2017. Dr. Xie has been a Managing Director of BlackRock since 2006 and joined BlackRock as a Director in 2005. Prior to joining BlackRock, Dr. Xie was a Senior Vice President of State Street Research & Management from 2001 to 2005. Dr. Liu, Director of BlackRock, has served as a portfolio manager of the Portfolio since June 2020. Dr. Liu has been a Director of Black Rock since 2016 and joined BlackRock in 2008 as a Vice President in 2005. Mr. Lee, Vice President of BlackRock, has served as a portfolio manager of the Portfolio since June 2020. Mr. Lee has been a Vice President of BlackRock since joining BlackRock in 2011. Prior to joining BlackRock, Mr. Lee was an analyst of Duquesne Capital Management from 2008 to 2010.

2. Thrivent Partner Healthcare Portfolio currently is considered to be diversified within the meaning of the 1940 Act.

Accordingly, the third sentence under "Principal Strategies" for Thrivent Partner Healthcare Portfolio in the "Summary Section" is deleted and replaced with the following: "The Portfolio invests primarily in equity securities of both U.S. and non-U.S. companies (including American Depositary Receipts and issuers in emerging markets)."

Non-Diversified Risk is deleted from the "Principal Risks" for Thrivent Partner Healthcare Portfolio in the "Summary Section."

The date of this Supplement is July 24, 2020.

Please include this Supplement with your Prospectus or Summary Prospectus.

36079

Thrivent Series Fund, Inc.

Supplement to the Prospectuses, Summary Prospectuses and Statement of Additional Information,

each dated April 30, 2020 Thrivent Aggressive Allocation Portfolio Thrivent Moderate Allocation Portfolio Thrivent Moderately Aggressive Allocation Portfolio Thrivent Moderately Conservative Allocation Portfolio Thrivent Balanced Income Plus Portfolio Thrivent Diversified Income Plus Portfolio

Thrivent Global Stock Portfolio Thrivent International Allocation Portfolio

(the "Portfolios")

Thrivent and the Portfolios are deeply saddened to share that Darren M. Bagwell, a portfolio co-manager of the Portfolios, recently passed away. Thrivent and the Portfolios' Directors mourn his passing and extend our deepest condolences to his loved ones.

All references to Mr. Bagwell are hereby deleted from the Prospectus, Summary Prospectus and Statement of Additional Information for each Portfolio. No other changes to the current portfolio management teams are anticipated at this time.

The date of this Supplement is August 4, 2020.

Please include this Supplement with your Prospectus, Summary Prospectus and Statement of Additional Information.

36129

Thrivent Series Fund, Inc.

Supplement to Prospectus and Thrivent Partner Growth Stock Portfolio Summary Prospectus

each dated April 30, 2020

Contractholders of Thrivent Partner Growth Stock Portfolio (the "Target Portfolio") recently approved the merger of the Target Portfolio into Thrivent Large Cap Growth Portfolio (the "Acquiring Portfolio"). The merger will occur on or about August 31, 2020. In connection with the merger, each investment in the Target Portfolio will automatically be transferred into the Acquiring Portfolio and the Target Portfolio will dissolve. Following the closing of the merger, all references to the Target Portfolio will be deleted from the prospectus.

The date of this Supplement is August 24, 2020.

Please include this Supplement with your Prospectus or Summary Prospectus.

36132

THRIVENT VARIABLE LIFE ACCOUNT I THRIVENT VARIABLE INSURANCE ACCOUNT A THRIVENT VARIABLE INSURANCE ACCOUNT B

THRIVENT VARIABLE ANNUITY ACCOUNT I THRIVENT VARIABLE ANNUITY ACCOUNT II THRIVENT VARIABLE ANNUITY ACCOUNT A THRIVENT VARIABLE ANNUITY ACCOUNT B THRIVENT VARIABLE ANNUITY ACCOUNT C

Supplement to Prospectus each dated April 30, 2020

with respect to Thrivent Partner Growth Stock Portfolio

Contractholders of Thrivent Partner Growth Stock Portfolio (the "Target Portfolio") recently approved the merger of the Target Portfolio into Thrivent Large Cap Growth Portfolio (the "Acquiring Portfolio"). The merger will occur on or about August 31, 2020. In connection with the merger, each investment in the Target Portfolio will automatically be transferred into the Acquiring Portfolio and the Target Portfolio will dissolve. Following the closing of the merger, all references to the Target Portfolio will be deleted from the prospectus.

The date of this Supplement is August 24, 2020.

Please include this Supplement with your Prospectus.

36132A

 ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download